Short-acting GHRH analog
The same modified GHRH(1-29) peptide without the albumin-binding DAC, so it clears fast (~30 min) - sold as 'Mod GRF 1-29'.
| Class / type | Short-acting GHRH analog |
|---|---|
| Category | Growth Hormone & Muscle |
| Status (Jul 2026) | Research use only |
Binds pituitary GHRH receptors to trigger a short GH pulse mimicking natural release; often paired with a GHRP (e.g., ipamorelin).
No approved use; off-label/research for GH optimization, body composition, sleep, recovery.
Pulsatile release closer to physiologic patterns; short duration seen as preserving feedback; user-reported recovery/sleep/skin benefits.
Requires frequent injections (often 1-3x/day); no long-term human data; possible fluid retention, tingling, injection-site reactions; purity concerns.
'Cleaner', pulse-like profile; base of GHRH+GHRP stacks.
NOT FDA-approved. Same regulatory path as CJC-1295 (Cat 2 2023, removed 2024, pending PCAC). Research-use-only; WADA-banned.